Nilotinib Clinical Trials Nilotinib RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Nilotinib for First-line Newly Diagnosed CML-CP Patients
Conditions:   Chronic Myeloid Leukemia, Chronic Phase;   Nilotinib Intervention:   Drug: Nilotinib Sponsor:   Shenzhen Second People's Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 8, 2019 Category: Research Source Type: clinical trials